✦ LIBER ✦

Reduction of tumorigenicity by an interferon-γ-gene-transduced tumor on another syngeneic tumor in a murine model

✍ Scribed by You Ichinose; Takashi Okino; Seiji Yamasaki; Yoshio Moriguchi; Tomoharu Sugie; Li Li; Shunji Kanaoka; Norimichi Kan; Yoshihiko Watanabe; Masayuki Imamura

Book ID: 112760062
Publisher: Springer
Year: 1999
Tongue: English
Weight: 84 KB
Volume: 29
Category: Article
ISSN: 1436-2813
DOI: 10.1007/bf02483058

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effectiveness of active specific imm

The effectiveness of active specific immunotherapy using interferon-γ-gene-transduced tumor cells in a murine tumor model

✍ Yoshio Moriguchi; Norimichi Kan; Takashi Okino; Yasufumi Teramura; Seiji Yamasak 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 300 KB

Induction of an endogenous tumor necrosi

Induction of an endogenous tumor necrosis factor in mice by murine recombinant interferon-γ combined with a lipid A subunit analog (GLA-60) of low toxicity

✍ Ikuo Saiki; Hiroaki Maeda; Takuma Sakurai; Jun Murata; Joji Iida; Makoto Kiso; A 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 973 KB

IL-12- and IL-2-induced tumor regression

IL-12- and IL-2-induced tumor regression in a new murine model of oral squamous-cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-γ

✍ Giovana R. Thomas; Zhong Chen; Ileana Enamorado; Caren Bancroft; Carter Van Waes 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 313 KB 👁 2 views

Therapy with IL-12 or IL-2 induces tumor regression in only a few patients with head-and-neck squamous cell carcinoma (SCC), and the factors promoting responsiveness have not been well defined. In this study, we examined whether combined IL-12 and IL-2 therapy can induce tumor regression in a new mu